Recursion Pharmaceuticals
clinical orally penetrating small molecule inhibitor mechanism of action | Recursion Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
January 2023
Slide
100 of 143
Related slides by other companies
Absci
Investor Presentation
July 2023
antibodies selected in tertiary lymphoid structures bind to cancer cells and are associated with favorable clinical outcomes | Absci
SentiBio
SPAC
October 2021
multiple potential cell sources are available for clinical application | SentiBio
Ocuphire Pharma
Investor Day
January 2022
phase clinical trials data supporting the zeta trial rat aches high levels in rat eye is orally | Ocuphire Pharma
MaxCyte
Investor Presentation
January 2024
enabled active clinical trials | MaxCyte
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io